De novo design of luciferases using deep learning

Hsien‐Wei Yeh(University of California, Santa Cruz), Christoffer Norn(University of Washington), Yakov Kipnis(Howard Hughes Medical Institute), Doug Tischer(University of Washington), Samuel J. Pellock(University of Washington), Declan Evans(University of California, Los Angeles), Pengchen Ma(University of California, Los Angeles), Gyu Rie Lee(University of Washington), Jason Z. Zhang(University of Washington), Ivan Anishchenko(University of Washington), Brian Coventry(Howard Hughes Medical Institute), Longxing Cao(University of Washington), Justas Dauparas(University of Washington), Samer Halabiya(University of Washington), Michelle DeWitt(University of Washington), Lauren Carter(University of Washington), K. N. Houk(University of California, Los Angeles), David Baker(Howard Hughes Medical Institute)
Nature
February 22, 2023
Cited by 445Open Access
Full Text

Abstract

Abstract De novo enzyme design has sought to introduce active sites and substrate-binding pockets that are predicted to catalyse a reaction of interest into geometrically compatible native scaffolds 1,2 , but has been limited by a lack of suitable protein structures and the complexity of native protein sequence–structure relationships. Here we describe a deep-learning-based ‘family-wide hallucination’ approach that generates large numbers of idealized protein structures containing diverse pocket shapes and designed sequences that encode them. We use these scaffolds to design artificial luciferases that selectively catalyse the oxidative chemiluminescence of the synthetic luciferin substrates diphenylterazine 3 and 2-deoxycoelenterazine. The designed active sites position an arginine guanidinium group adjacent to an anion that develops during the reaction in a binding pocket with high shape complementarity. For both luciferin substrates, we obtain designed luciferases with high selectivity; the most active of these is a small (13.9 kDa) and thermostable (with a melting temperature higher than 95 °C) enzyme that has a catalytic efficiency on diphenylterazine ( k cat / K m = 10 6 M −1 s −1 ) comparable to that of native luciferases, but a much higher substrate specificity. The creation of highly active and specific biocatalysts from scratch with broad applications in biomedicine is a key milestone for computational enzyme design, and our approach should enable generation of a wide range of luciferases and other enzymes.


Related Papers

No related papers found

Powered by citation graph analysis